ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL2108413
CHEMBL2108413
Compound Name BIVATUZUMAB
ChEMBL Synonyms BIVATUZUMAB
Max Phase 1
Trade Names

Sources

  • USP Dictionary of USAN and International Drug Names

Molecule Features

CHEMBL2108413 compound icon
Drug Type:Antibody Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:Unclassified Parenteral:Unclassified Topical:Unclassified Black Box:Unclassified Availability Type:Unclassified

Mechanism of Action

Mechanism of Action ChEMBL Target References
CD44 antigen binding agent CD44 antigen PMC

Indications

MESH Heading MESH ID EFO ID EFO Term Max phase for indication References
Carcinoma, Squamous CellD002294EFO:0000707squamous cell carcinoma1ClinicalTrials
Head and Neck NeoplasmsD006258EFO:0004284upper aerodigestive tract neoplasm1ClinicalTrials
Breast NeoplasmsD001943EFO:0003869breast neoplasm1ClinicalTrials

Clinical Data

ClinicalTrials.gov BIVATUZUMAB
The Cochrane Collaboration BIVATUZUMAB

Compound Cross References

ChemSpider ChemSpider Identifier not yet assigned
spacer
spacer